Open-Label Study of 18F-mFBG for Imaging Neuroblastoma
NCT04724369
·
clinicaltrials.gov ↗
PHASE3
Phase
ACTIVE_NOT_RECRUITING
Status
43
Enrollment
INDUSTRY
Sponsor class
Conditions
Neuroblastoma
Interventions
DRUG:
18F-MFBG
Sponsor
Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC)
Collaborators
[object Object]
[object Object]